Christy J. Oliger
Director · Zenas BioPharma, Inc.
- 2025
- Sep 2, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Christy J. Oliger files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $40.00M in BCAX purchases and sales in the last 12 months
- Leon O. Moulder Jr. - $4.12M in ZBIO purchases and sales in the last 12 months
- Claire Mazumdar - $3.59M in BCAX purchases and sales in the last 12 months
- Ryan Cohlhepp - $3.46M in BCAX purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $3.00M in ZBIO purchases and sales in the last 12 months
- Ivan Hyep - $2.40M in BCAX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christy J. Oliger?
Christy J. Oliger is a corporate insider, tracked as Director of Zenas BioPharma, Inc. (ZBIO). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Christy J. Oliger submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.